Recalls for ARB

Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
07/03/2013 Medical Recall

Enteropathy may develop months to years after starting olmesartan, and sometimes requires hospitalization.

  • Company:
    ARB